Navigation Links
Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year
Date:12/10/2008

a href="http://www.solosendoscopy.com/" target="_new">www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Solos Endoscopy, Inc.s Mammo View(TM) System Now Used in Womens Hospital of Baton Rouge, LA
2. Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com
3. Bio-Imaging Technologies Partners with AG Mednet to Offer Complete Imaging Solution for Clinical Trials : --Partnership Increases Trial Efficiency and Enhances Data Quality--
4. Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
5. USAID Increases Assistance for Zimbabwe Cholera Outbreak
6. Cancer Mortality Increases With Cancer Cell Replikin Count
7. Stryker Increases Annual Dividend by Over 20%
8. Portable CT increases chance of stroke survival and recovery
9. Dual-head gamma camera increases ability to detect breast tumors not seen on mammography
10. Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
11. Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Within3 Expands into Mobile Applications 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 1New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 3New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 4Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 1Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 2Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 3Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 4